Daniel J. Hicklin - Jan 2, 2025 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jonathan Owen, Attorney-in-fact
Stock symbol
HOWL
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/6/2025, 05:41 PM
Previous filing
Jan 4, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOWL Stock Option (right to buy) Award $0 +593K $0.00 593K Jan 2, 2025 Common Stock 593K $1.56 Direct F1
transaction HOWL Stock Option (right to buy) Award $0 +186K $0.00 186K Jan 2, 2025 Common Stock 186K $1.56 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.

Remarks:

President and Chief Executive Officer